Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(1)

Multispectral Optoacoustic Tomography

1 trial

not_applicable

university-of-erlangennürnberg-medical-school

1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT05083806Not ApplicableCompleted

MSOT in Pompe Disease

Pompe DiseasePompe Disease (Late-onset)Pompe Disease Infantile-Onset+1 more

StudydirectorStart date: 2022-05-17

Research Network

Collaboration Network

2 collaborators·1 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Glycogen Storage Disease Type II1 Pompe Disease (Infantile-Onset)1 Pompe Disease Late-Onset1 Pompe's Disease Juvenile Onset1

Affiliations

University Hospital Erlangen

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ferdinand Knieling, MD

University Hospital Erlangen

Moderately Similar

2 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease (Infantile-Onset)Pompe Disease Late-Onset+1 more

Worked with same sponsors:

University of Erlangen-Nürnberg Medical School

Collaborated on 1 trial

Similarity Score44%

Paolo Banfi, MD

IRCCS Fondazione Don Carlo Gnocchi

1 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score15%

Nadine A.M.E. van der Beek, Dr.

Erasmus Medical Center

1 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score15%

Priya Kishnani, MD

Duke University

8 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score15%

Tim Preijers, Dr.

Erasmus Medical Center

1 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score15%

Tahseen Mozaffar, MD

University of California Irvine Health

2 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score15%

Pieter A. van Doorn, Prof. dr.

Erasmus Medical Center

1 trials

Shared therapeutic areas:

Glycogen Storage Disease Type IIPompe Disease Late-Onset

Similarity Score15%

Priya Kishnani

Duke University

1 trials

Shared therapeutic areas:

Glycogen Storage Disease Type II

Similarity Score8%

Benedikt Schoser, MD

Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen Munich, Germany

2 trials

Shared therapeutic areas:

Glycogen Storage Disease Type II

Similarity Score8%

Dwight d Koeberl, MD, PhD

Duke University

3 trials

Shared therapeutic areas:

Glycogen Storage Disease Type II

Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05083806Not ApplicableStudyDirector

MSOT in Pompe Disease

Pompe DiseasePompe Disease (Late-onset)Pompe Disease Infantile-Onset+1 more

Completed

All 1 trials loaded